Fortive (FTV) Q3 2025 earnings review
Margin Expansion and Massive Buyback Drive Beat & Raise in First 'New Fortive' Quarter
Fortive's first quarter as a streamlined entity post-spin-off beat expectations on the bottom line, driven by powerful margin expansion and cost discipline. While core revenue growth was tepid at 1.9%, Adjusted EBITDA margins surged 220 basis points to 30.1%, fueling a 15% increase in adjusted EPS to $0.68. Management raised full-year EPS guidance and signaled confidence by deploying $1 billion to share repurchases, a significant acceleration of its new capital allocation strategy. The results demonstrate strong operational execution, but the modest top-line growth and a guided Q4 slowdown highlight ongoing macro uncertainties in Europe and cautious customer spending.
🐂 Bull Case
The company demonstrated impressive operating leverage. Adjusted EBITDA margins expanded by 220 bps to 30.1%, proving the 'New Fortive' can drive profitability through cost discipline and streamlining, even in a low-growth environment.
The deployment of $1 billion for share buybacks, retiring ~6% of shares, is a strong vote of confidence from management and immediately puts their new, more balanced capital allocation strategy into action.
Management raised its full-year 2025 adjusted EPS guidance to $2.63-$2.67, up from $2.50-$2.60, reflecting the strong Q3 performance and the accretive impact of the buyback.
🐻 Bear Case
Core revenue growth of 1.9% remains weak, and the outlook for Q4 suggests a moderation from even this level. Persistent softness in Europe and cautious spending in healthcare cap the near-term growth potential.
Free cash flow declined 6% year-over-year to $266 million, lagging the strong 10% growth in adjusted EBITDA. This disconnect raises questions about working capital management and the quality of earnings.
⚖️ Verdict: 🟢
Bullish. The first quarter of the 'New Fortive' successfully demonstrated the thesis: a simpler company can execute with focus and discipline. The significant margin expansion and aggressive share buyback more than offset the tepid revenue growth. This performance sets a strong foundation and signals management's confidence in the go-forward plan.
Key Themes
New Capital Allocation Strategy Kicks Off With $1B Buyback
Fortive made a definitive statement on its new capital allocation policy by deploying $1 billion to repurchase approximately 21 million shares. This move, funded by cash and proceeds from the Ralliant spin-off dividend, underscores a shift towards a more balanced approach between M&A and direct shareholder returns. Management cited the stock's attractive valuation as a key driver, signaling a dynamic and opportunistic approach to creating shareholder value.
Profitability Surges on Cost Discipline
Adjusted EBITDA margin reached 30.1%, a 220 basis point year-over-year improvement. This was driven by what management described as 'deliberate organizational streamlining' and a 'sharpened focus on corporate cost discipline'. Both segments contributed, with IOS Adj. EBITDA margin hitting 34.6% (+130 bps) and AHS reaching 28.1% (+120 bps). While some one-time items contributed, the performance highlights the leaner cost structure of the new company.
Core Growth Remains Sluggish with Weak European Exposure
While the 1.9% core growth was a recovery from Q2's -0.7%, it remains low. The call transcript highlighted that Europe 'worsened modestly driven by weakening macro conditions' and was down year-over-year. Furthermore, guidance implies growth will decelerate again in Q4. This contradicts the 'acceleration in the business' narrative on the top line, indicating profit growth is currently driven by cost-cutting rather than strong demand.
Innovation Focus on High-Growth Verticals
Management is focusing its innovation and commercial efforts on faster-growing markets. Recent product launches include ServiceChannel's AI-powered SaaS for work order insights and Fluke's GFL 1500 for the high-growth solar operations vertical. The company is also deploying more resources towards verticals like distributed energy, data centers, and defense, and regions like India, which saw 'significant acceleration' in the quarter.
AHS Segment Showing Sequential Improvement but Caution Lingers
The Advanced Healthcare Solutions segment grew a modest 1.1% core. Management noted 'sequential improvement in demand for healthcare equipment and consumables' compared to Q2, driven by customers executing on deferred orders. However, they also stated that 'healthcare customers continue to exhibit caution as they navigate recent changes to healthcare reimbursement and funding policy,' suggesting the recovery path may be gradual.
Other KPIs
Declined 6% year-over-year, contrasting with the 10.4% growth in Adjusted EBITDA. While the company maintains a trailing-twelve-month FCF conversion rate above 100% of adjusted net income, the negative growth in the quarter warrants monitoring for potential working capital pressures.
The larger segment performed slightly ahead of the company average, driven by resilient demand for professional instrumentation and strong growth in facility and asset lifecycle software. Margin expansion was a key highlight, with Adjusted EBITDA margin increasing 130 bps to 34.6%.
The segment's top-line growth was muted by cautious hospital capital spending due to policy uncertainty. However, results showed sequential improvement from Q2, and software products continued to deliver solid growth. Profitability was strong, with GAAP Operating Margin up 150 bps to 12.9%.
Guidance
Accelerating. This is a significant raise from the prior guidance of $2.50 - $2.60. The increase reflects the Q3 earnings beat and the accretive effect of the substantial share repurchase program. The midpoint of the new range is $2.65, approximately 4.8% higher than the prior midpoint.
Decelerating. Management expects overall core growth to moderate from Q3's +1.9%. AHS is guided to be in line with Q3 (~1.1%), while IOS is expected to see 'very modest' growth, a deceleration from its +2.2% in Q3. This suggests a cautious near-term top-line outlook.
Key Questions
Margin Sustainability
Q3 adjusted EBITDA margin jumped over 200 bps to 30.1%, with some one-time benefits mentioned. As you reinvest for growth in Q4 and into 2026, what do you view as the sustainable, normalized margin level for the 'New Fortive'?
Free Cash Flow Disconnect
Adjusted EBITDA grew over 10% but Free Cash Flow declined 6% year-over-year. Can you provide more detail on the drivers of this gap? Was it primarily working capital, and should we expect FCF growth to re-align with profit growth in Q4 and beyond?
Capital Allocation Post-Buyback
After deploying $1 billion on repurchases, can you update us on your capital priorities? How do you weigh further buybacks against the M&A funnel, and what are the strategic and financial criteria for a potential bolt-on acquisition?
IOS Growth Moderation
You're guiding for 'very modest' core growth in IOS for Q4, a deceleration from Q3. Can you elaborate on the specific end markets or product lines where you are seeing this slowdown?